Larvol Delta - Evaluation-of-Efficacy-Safety-and-Immunogenicity-of-GX19N-in-Healthy-Individuals-Who-Have-Received-COVID19-Vaccines

GX-19N - Genexine, Binex, GenNBio, PT Kalbe Farma

http://clinicaltrials.gov/ct2/show/NCT05067946

Apr 12, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next